Eli Lilly and Company
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2007 | — | — | $3.22B |
| FY2008 | $22.47B | $29.21B | $5.50B |
| FY2009 | $17.94B | $27.46B | $4.46B |
| FY2010 | $18.58B | $31.00B | $5.99B |
| FY2011 | $20.12B | $33.66B | $5.92B |
| FY2012 | $19.63B | $34.40B | $4.02B |
| FY2013 | $17.62B | $35.25B | $3.83B |
| FY2014 | $20.93B | $36.31B | $3.87B |
| FY2015 | $21.00B | $35.57B | $3.67B |
| FY2016 | $24.80B | $38.81B | $4.58B |
| FY2017 | $33.39B | $44.98B | $6.54B |
| FY2018 | $34.08B | $43.91B | $7.32B |
| FY2019 | $36.68B | $39.29B | $2.34B |
| FY2020 | $40.99B | $46.63B | $3.66B |
| FY2021 | $39.83B | $48.81B | $3.82B |
| FY2022 | $38.84B | $49.49B | $2.07B |
| FY2023 | $53.23B | $64.01B | $2.82B |
| FY2024 | $64.44B | $78.72B | $3.27B |
| FY2025 | $85.94B | $112.48B | $7.27B |